ATF3 and Insulin resistance: Here, we demonstrated that loss of ATF3 in vivo aggravated HFD-induced obesity and metabolic dysfunction in mice, with increased TG level, insulin resistance, and hepatic steatosis, along with loss of normal thermoregulation under cold stress and decreased energy expenditure.